Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis | MicrobiomeTrials← Back to trialsNCT07459452
Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04Est. Completion: 2027-10
Enrollment target: 135 participants Other microbiome trials you might be interested in
Perennial Allergic Rhinitis (PAR)
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perenni…
Huntington Beach, United StatesEst. completion Oct 22, 2026
Perennial Allergic Rhinitis (PAR)
This is a randomized, double-blind, placebo-parallel controlled phase II study to evaluate the safety and efficacy of CM…
Beijing, ChinaEst. completion Jun 2028
Phase 4
Recruiting
Allergic Rhinitis Due to Allergens
The purpose of this study is to determine if the investigational drug product ("study drug"), Dymista (azelastine hydroc…
Beijing, ChinaEst. completion Oct 2026